COYA and RDY Related Headlines

Go Back

Aug 25, 2025 08:00AM Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

COYA and RDY Related Press Releases

Go Back

Aug 25, 2025 08:00AM Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

COYA and RDY Related SEC Filings

Go Back